CAS 179102-65-9 MFCD79102659
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Arakida Y, et al. Effects of lipid mediator antagonists on predominant mediator-controlled asthmatic reactions in passively sensitized guinea pigs. J Pharmacol Exp Ther. 1999 Sep;290(3):1285-91.
- [1]. Arakida Y, et al. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD 4 and TXA 2 receptors. J Pharmacol Exp Ther. 1998 Nov;287(2):633-9.
- [1]. Arakida Y, et al. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD 4 and TXA 2 receptors. J Pharmacol Exp Ther. 1998 Nov;287(2):633-9.
- [2]. Arakida Y, et al. Effects of lipid mediator antagonists on predominant mediator-controlled asthmatic reactions in passively sensitized guinea pigs. J Pharmacol Exp Ther. 1999 Sep;290(3):1285-91.